Therapeutic Cataract & Refractive
Lens Technology
Glasses
Ptosis
AMD
COVID-19
DME
Ocular Surface Disease
Optic Relief
Geographic Atrophy
Cornea
Conjunctivitis
LASIK
Myopia
Presbyopia
Allergy
Nutrition
Pediatrics
Retina
Cataract
Contact Lenses
Lid and Lash
Dry Eye
Glaucoma
Refractive Surgery
Comanagement
Blepharitis
OCT
Patient Care
Diabetic Eye Disease
Technology

Augmenting corneal thickness with FDA-approved hypotonic riboflavin

Name: Augmenting corneal thickness with FDA-approved hypotonic riboflavin
Uploaded: 2022-03-12T18:00:00.000Z
Description: Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.

March 12, 2022

Alex Delaney-Gesing, Senior Editor

Video

Conference|SECO

Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.

Daniel Fuller, OD, FAAO Dipl., FSLS, discusses his SECO 2022 presentation "Augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin," with Optometry Times®' Alex Delaney-Gesing.

See more conference coverage